« Return to News | Technology Solutions

ABPI launches clinical trial disclosure toolkit

Friday, August 16, 2013 11:36 AM

The Association of the British Pharmaceutical Industry (ABPI) has launched a clinical trial disclosure toolkit to help pharmaceutical companies meet clinical trial transparency requirements.

The toolkit has 11 elements, including good practice guidelines, disclosure checklists and template standard operating procedure. These documents are intended as an additional support to guide companies of all sizes through the different steps of the disclosure process.

"The ABPI is a strong advocate for transparency in clinical trial information,” said Stephen Whitehead, ABPI chief executive. “Earlier this year we committed to providing a clinical trial disclosure toolkit to companies and this is now available on our website for any company to use. The pharmaceutical industry has been, and continues to be, committed to addressing the issues relating to transparency in clinical research. 

"Research is a truly global activity, with the U.K. supplying less than 2% of patients to global clinical trials. As part of a global industry, we are actively engaging with our European and international counterparts, as well as many other stakeholders, to input into ongoing discussions around clinical trial transparency." 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.